![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Acquisition of Nitinol Implant Company Strengthens Johnson & Johnson Medical Devices Position in Elective Extremity Surgery, the Fastest Growing Segment in Orthopaedics.
DePuy Orthopaedics, Inc part of the DePuy Synthes Companies of Johnson & Johnson, announced today that it has acquired privately-held BioMedical Enterprises, Inc. (BME), a leading manufacturer of Nitinol orthopaedic implants for small bone fixation. The implants are used to treat bunions, hammertoes and other foot and ankle deformities, as well as hand and wrist deformities. The BME acquisition reinforces Johnson & Johnson Medical Devices focus on accelerating meaningful innovation and strengthening DePuy Synthes’ portfolio for elective extremity procedures – providing a more complete solution for foot and ankle and hand and wrist specialists.
BME is based in San Antonio, Texas and serves healthcare professionals in the United States and select markets throughout the world. BME, founded more than a decade ago, was one of the first U.S. manufacturers of Nitinol metal implants for musculoskeletal fixation and is a market leader in the use of memory metal implants for bone fixation. Nitinol is a nickel-titanium alloy that provides dynamic continuous active compression, which helps to promote healing after bone fixation. BME implants come ready-to-use on a sterilized, pre-loaded, fully disposable insertion tool.
Ciro Römer, Company Group Chairman, DePuy Synthes said that BME’s technology is an excellent complement to our comprehensive portfolio of solutions that spans all of orthopaedics,.The BME portfolio will be integrated into our trauma platform, where we will be able to expand the availability of these solutions, increase the pace of innovation in this area, and reach more patients around the world. We look forward to welcoming the BME employees to DePuy Synthes.
DePuy Synthes is the global market leader in the foot and ankle and hand and wrist markets for bone fixation in trauma. The company’s implants and instruments are also used for the surgical treatment of orthopaedic deformities and tumor diseases.
About DePuy Synthes Companies
DePuy Synthes Companies of Johnson & Johnson provides the most comprehensive orthopaedic and neurological solutions in the world. The company offers an unparalleled breadth of products, services, programs and research and development capabilities. DePuy Synthes Companies’ solutions in the specialties of joint reconstruction, trauma, neurological, craniomaxillofacial, spinal surgery and sports medicine are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
For more information visit, www.depuysynthes.com.
Contact:
Amber Hamilton(212) 266-0062
Christie Corbett (508) 977-2619 Jason Valmore
(732) 524-3709 Investor Relations
